Abstract
The incidence of lower extremity artery disease (LEAD) in patient receiving hemodialysis is remarkably higher than the general population. The treatment strategy and prognosis for LEAD patients differs depending on whether a patient has intermittent claudication (IC) or critical limb-threatening ischemia (CLTI). However, the distinction between the prognosis in HD-dependent patients with IC and CLTI has not been fully elucidated. This study is to determine whether indication of PAD has a distinct impact on major adverse cardiovascular and cerebrovascular events (MACCE) and limb events in patients receiving hemodialysis. The current study included 2321 prospectively enrolled patients from the Tokyo taMA peripheral vascular intervention research ComraDE registry (UMIN-CTR no. UMIN000015100) between September 2014 and December 2016. Out of the enrolled patients, 1644 were not receiving hemodialysis (non-HD patients) and 603 were receiving hemodialysis (HD patients). A composite of all-cause death, myocardial infarction, and stroke events defined as MACCE; while limb events were defined as a composite of unscheduled major amputation, unscheduled major lower limb surgery, acute limb ischemia, unscheduled endovascular treatment, and target lesion revascularization. Propensity score matching was applied among the non-HD and HD patients, in whole group, IC subgroup, and CLTI subgroup. Kaplan–Meier analysis was used for the analysis of outcomes for the whole group, IC subgroup, and the CLTI subgroup. CLTI accounted for 75.5% of the HD patients, whereas IC was 63.4% in the non-HD patients. The HD patients exhibited more frequent below-the-knee lesions than those in the non-HD patients in both IC (p = 0.01) and CLTI (p < 0.001) subgroups. Overall, HD patients exhibited a significantly higher rate of MACCE at 24 months. This trend was similar for limb events in whole group and CLTI subgroup. In contrast, no significant differences in outcomes for limb events were found in IC subgroup. Although, prognosis after EVT in HD patients were significantly worse than non-HD patients, comparable outcome with non-HD patients was observed in the patients treated for IC. Clinical trial registration: This study was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR No. UMIN000015100).
Similar content being viewed by others
References
Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382(9901):1329–1340
Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lüders F, Gebauer K, Roeder N, Berger K, Malyar NM (2015) Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J 36(15):932–938
Sasaki M, Mitsutake Y, Ueno T, Fukami A, Sasaki KI, Yokoyama S, Ohtsuka M, Nakayoshi T, Itaya N, Chibana H, Sasaki M, Ishimatsu T, Kagiyama K, Fukumoto Y (2020) Low ankle brachial index predicts poor outcomes including target lesion revascularization during the long-term follow up after drug-eluting stent implantation for coronary artery disease. J Cardiol 75(3):250–254
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135(12):e686–e725
Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, ESC Scientific Document Group (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 39(9):763–816
Iida O, Nakamura M, Yamauchi Y, Fukunaga M, Yokoi Y, Yokoi H, Soga Y, Zen K, Suematsu N, Inoue N, Suzuki K, Hirano K, Shintani Y, Miyashita Y, Urasawa K, Kitano I, Tsuchiya T, Kawamoto K, Yamaoka T, Uesugi M, Shinke T, Oba Y, Ohura N, Uematsu M, Takahara M, Hamasaki T, Nanto S, Investigators OLIVE (2015) 3-year outcomes of the OLIVE Registry, a prospective multicenter study of patients with critical limb ischemia: a prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. JACC Cardiovasc Interv 8(11):1493–1502
Iida O, Takahara M, Soga Y, Kodama A, Terashi H, Azuma N, SPINACH Investigators (2017) Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: The SPINACH Study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv 10(12):e005531
Meecham L, Popplewell M, Bate G, Patel S, Bradbury AW (2019) Contemporary (2009–2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999–2004). J Vasc Surg 69(6):1840–1847
O’Hare A, Johansen K (2001) Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 12(12):2838–2847
Fallon JM, Goodney PP, Stone DH, Patel VI, Nolan BW, Kalish JA, Zhao Y, Hamdan AD, Vascular Study Group of New England (2015) Outcomes of lower extremity revascularization among the hemodialysis-dependent. J Vasc Surg 62(5):1183–1191
Meyer A, Lang W, Borowski M, Torsello G, Bisdas T, CRITISCH collaborators (2016) In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization. J Vasc Surg 63(4):966–973
Moussa Pacha H, Al-Khadra Y, Darmoch F, Soud M, Mamas MA, Moussa Pacha A, Zaitoun A, Kaki A, AlJaroudi WA, Alraies MC (2020) In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients. Catheter Cardiovasc Interv 95(3):E84–E95
Hokimoto S, Sakamoto K, Akasaka T, Kaikita K, Honda O, Naruse M, Ogawa H, Multi-center Study of Hemodialysis Patients Undergoing Invasive Cardiovascular Procedures Study Investigators (2015) High mortality rate in hemodialysis patients who undergo invasive cardiovascular procedures related to peripheral artery disease—community-based observational study in Kumamoto Prefecture. Circ J 79(6):1269–1276
Dawson DB, Telles-Garcia NA, Atkins JL, Mina GS, Abreo AP, Virk CS, Dominic PS (2021) End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: systematic review and meta-analysis. Catheter Cardiovasc Interv 98(2):297–307
Higashitani M, Uemura Y, Mizuno A, Utsunomiya M, Yamaguchi T, Matsui A, Ozaki S, Tobita K, Tosaka A, Oida A, Suzuki K, Kodama T, Jujo K, Doijiri T, Takahashi Y, Matsuno S, Kaneko N, Moriguchi A, Kishi S, Anzai H, Investigators T-C (2018) Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease—short-term results of the Toma-Code Registry. Circ J 82(7):1917–1925
Rocha-Singh KJ, Zeller T, Jaff MR (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 83(6):E212–E220
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl 48(3):452–458
Rajagopalan S, Dellegrottaglie S, Furniss AL, Gillespie BW, Satayathum S, Lameire N, Saito A, Akiba T, Jadoul M, Ginsberg N, Keen M, Port FK, Mukherjee D, Saran R (2006) Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 114(18):1914–1922
Gupta T, Harikrishnan P, Kolte D, Khera S, Subramanian KS, Mujib M, Masud A, Palaniswamy C, Sule S, Jain D, Ahmed A, Lanier GM, Cooper HA, Frishman WH, Bhatt DL, Fonarow GC, Panza JA, Aronow WS (2015) Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. Am J Cardiol 115(8):1033–1041
Ohtake T, Oka M, Ikee R, Mochida Y, Ishioka K, Moriya H, Hidaka S, Kobayashi S (2011) Impact of lower limbs’ arterial calcification on the prevalence and severity of PAD in patients on hemodialysis. J Vasc Surg 53(3):676–683
Okamoto S, Iida O, Mano T (2017) Current perspective on hemodialysis patients with peripheral artery disease. Ann Vasc Dis 10(2):88–91
Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB (2008) Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 48(3):619–625 (discussion 625-6)
Elsharkawi M, Elsherif M, Ghoneim B, O’Sullivan M, McCormack E, Tawfick W, Sultan S (2021) Significance of distal runoff score as a key influencer on clinical outcomes after endovascular interventions for superficial femoral artery disease. Ann Vasc Surg 73:234–243
Aihara H, Soga Y, Mii S, Okazaki J, Yamaoka T, Kamoi D, Shintani Y, Ishikawa T, RECANALISE Registry Investigators (2014) Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ J 78(2):457–464
Lo RC, Bensley RP, Dahlberg SE, Matyal R, Hamdan AD, Wyers M, Chaikof EL, Schermerhorn ML (2014) Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease. J Vasc Surg 59(2):409-418.e3
Sachwani GR, Hans SS, Khoury MD, King TF, Mitsuya M, Rizk YS, Zachwieja JA, Sayed L (2013) Results of iliac stenting and aortofemoral grafting for iliac artery occlusions. J Vasc Surg 57(4):1030–1037
Parvar SL, Ngo L, Dawson J, Nicholls SJ, Fitridge R, Psaltis PJ, Ranasinghe I (2021) Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis. Eur Heart J 43(1):32–40
Acknowledgements
None
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interests
All authors have no relationships with the industry or other relevant entities to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Iwai, T., Yamaguchi, T., Ueshima, D. et al. Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis. Heart Vessels 38, 488–496 (2023). https://doi.org/10.1007/s00380-022-02195-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-022-02195-9